Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmax Pharmaceuticals was a UAE-based pharmaceutical manufacturer and distributor focused on affordable branded generic medicines. The company operated a GCC- and EU GMP-certified manufacturing site in Dubai and specialized primarily in oral solid dosage pharmaceuticals, with products spanning chronic-care therapeutic areas such as cardiology, diabetes, gastroenterology, and neurology. Pharmax also supported licensing, manufacturing, packaging, and regional supply activities across the Middle East and Africa. In 2023, Pharmax was integrated into Acino, strengthening Acino's manufacturing and commercial footprint in the Middle East. As a result, Pharmax no longer appears to operate as an independent active company brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmax Pharmaceuticals.